Proteomics International, the leader in predictive diagnostics for diabetic kidney disease,...
PromarkerD Development Advances in China
Proteomics International is pleased to announce significant advances towards commercialisation of PromarkerD as an In vitro Diagnostic (IVD) test in China, with the grant of a key patent and funds secured to initiate kit manufacture.